Roche Backs 2023 View
By Adria Calatayud Roche Holding confirmed its 2023 guidance after a fall in sales for the first nine months, with growth in its pharmaceutical division...
Stay updated with breaking news from Ch Rog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Adria Calatayud Roche Holding confirmed its 2023 guidance after a fall in sales for the first nine months, with growth in its pharmaceutical division...
By Adria Calatayud Shares in Roche Holding fell after the company reported lower sales for the first nine months and flagged a bigger hit from currency...
By Colin Kellaher Shares of Tempest Therapeutics rose more than sevenfold in premarket trading Wednesday after the clinical-stage oncology company reported...
Biogen Inc. said late Friday the Food and Drug Administration approved its biosimilar version of Roche ‘s arthritis treatment Actemra. Biogen said its...
By Adria Calatayud Shares in Roche Holding rose Wednesday after the company released interim results from a late-stage clinical trial of a combination of two...